MRK – Merck & Co Stock Premarket Price
MRK Premarket Chart
About Merck & Co Inc
Merck & Co. Inc. is a renowned multinational pharmaceutical company. Founded in 1891, Merck is recognized for its contributions to the healthcare sector, including the development of prescription drugs and vaccines. The company’s products address a wide range of medical conditions and health challenges. Merck’s commitment to medical research and innovation has led to significant advancements in the field of pharmaceuticals. As a leader in the healthcare industry, Merck continues to play a crucial role in improving global health and well-being.
Latest News
- Klarna opens at $52 per share in NYSE debut after pricing IPO above range
- Stocks making the biggest moves midday: Oracle, Chewy, Broadcom, GameStop & more
- Wells Fargo CEO says Trump is entitled to be vocal about the Fed
- Wells Fargo CEO sees ‘more downside’ to U.S. economy as lower-income consumers struggle
- Uber partners with fintech firm Pipe to offer loans to small businesses
- Stocks making the biggest moves premarket: Oracle, GameStop, Novo Nordisk, Synopsys and more
- ACA cliff may mean ‘huge premium shock’ for 22 million people in 2026, expert says
- More investors want public and private assets in their portfolio. Now there’s a benchmark to track this combo
- Record share of U.S. businesses divert China investments. Top choice: Southeast Asia
- Klarna prices IPO at $40, above online lender’s expected range
- JPMorgan CEO Jamie Dimon says the economy ‘is weakening’
- Fund aims to let investors tail Bill Ackman’s trades following success of Warren Buffett copycat ETF
- Stocks making the biggest moves midday: UnitedHealth, Kingsoft Cloud, Brighthouse Financial & more
- Stocks making the biggest moves premarket: Fox, Apple, Nebius Group, Dell Technologies and more
- Stocks making the biggest moves after hours: Fox, Dell, Mission Produce and more
- ‘We’re all kind of in shock.’ Oracle’s revenue projections leave analysts slackjawed
- Oracle pops 27% on cloud growth projections even as earnings miss estimates
- Stocks making the biggest moves after hours: Oracle, GameStop, Synopsys and more
- Wall Street’s dilemma: How Fed rate cut hopes clashed with slowing jobs growth
- Broadcom stock jumps 15% on new $10 billion customer that analysts say is OpenAI
- We raised our Broadcom price target after a stock pop that was all about the conference call
- Lululemon shares plunge as earnings guidance falls well short of estimates
- Broadcom earnings primer: AI chip demand and growth are key
- Salesforce slump deepens as stock drops 7% on disappointing guidance
- Salesforce’s soft guidance gives the skeptics more fuel. Here’s why we are hanging on
- C3 AI reports declining revenue, announces new CEO to replace Siebel
- Salesforce issues weak revenue guidance even as earnings beat estimates
- Figma’s stock plunges after company’s first earnings report since IPO
- American Eagle stock soars 20% as retailer says Sydney Sweeney campaign is ‘best’ to date, beats earnings
- Macy’s shares pop 10% as retailer tops earnings estimates, raises outlook